Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-013339
Filing Date
2023-05-19
Accepted
2023-05-19 16:15:13
Documents
2
Period of Report
2023-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1643
2 EX-24 DOCUMENT attachment1.htm EX-24 4422
  Complete submission text file 0000899243-23-013339.txt   7531
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 45 TENNYSON ST. SOMERVILLE MA 02145
Business Address
ALTSCHULLER Susan (Reporting) CIK: 0001817988 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39311 | Film No.: 23940221